
Alphabet Inc.
About Alphabet Inc.’s 13F portfolio
Alphabet Inc. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Alphabet Inc. reported $99.1B across 28 US-listed positions (). Its largest position is SPACE EXPLORATION TECHN CORP (SPCX) at 95% of the reported book, and its ten biggest holdings make up 100% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | TSX: SPCX SPACE EXPLORATION TECHN CORP | $143.50 +1.27% | 95% | 551.2M | $94.2B |
| 2 | NYSE: PL PLANET LABS PBC | $12.05 −3.52% | 1.2% | 35.2M | $1.2B |
| 3 | NASDAQ: ASTS AST SPACEMOBILE INC | $25.49 −7.61% | 0.8% | 8.9M | $794.7M |
| 4 | NASDAQ: CME CME GROUP INC | $310.25 −0.42% | 0.8% | 3.5M | $769.4M |
| 5 | NASDAQ: ARM ARM HOLDINGS PLC | $182.76 −0.34% | 0.7% | 2.0M | $695.2M |
| 6 | NASDAQ: RVMD REVOLUTION MEDICINES INC | $159.82 −1.76% | 0.6% | 2.9M | $551.8M |
| 7 | NASDAQ: FRSH FRESHWORKS INC | $12.79 −1.24% | 0.2% | 16.2M | $164.0M |
| 8 | NASDAQ: PBLS PARABILIS MEDICINES INC | — — | 0.1% | 4.9M | $134.6M |
| 9 | NASDAQ: TEM TEMPUS AI INC | $63.62 +0.30% | 0.1% | 1.6M | $89.9M |
| 10 | NASDAQ: GTLB GITLAB INC | $44.50 −0.18% | 0.1% | 2.7M | $83.2M |
| 11 | NYSE: PATH UIPATH INC | $11.73 −5.33% | 0.1% | 7.0M | $76.5M |
| 12 | TSX: LIFE ETHOS TECHNOLOGIES INC | $16.82 −2.10% | 0.1% | 3.6M | $65.7M |
| 13 | NASDAQ: PRME PRIME MEDICINE INC | $3.82 −0.52% | 0.1% | 16.6M | $61.1M |
| 14 | NASDAQ: FRVO FERVO ENERGY CO | — — | 0.1% | 1.8M | $51.5M |
| 15 | NASDAQ: PAYP PAYPAY CORP | — — | 0.0% | 3.1M | $44.8M |
| 16 | NASDAQ: MAZE MAZE THERAPEUTICS INC | $31.20 −5.08% | 0.0% | 1.4M | $41.4M |
| 17 | NASDAQ: RLAY RELAY THERAPEUTICS INC | $16.51 +0.24% | 0.0% | 1.4M | $26.4M |
| 18 | NASDAQ: BBOT BRIDGEBIO ONCOLOGY THERAPEUT | $1.81 −6.96% | 0.0% | 2.8M | $21.5M |
| 19 | NYSE: OSCR OSCAR HEALTH INC | $27.57 −7.61% | 0.0% | 482K | $13.7M |
| 20 | NASDAQ: BEAM BEAM THERAPEUTICS INC | $21.01 +1.74% | 0.0% | 322K | $11.0M |
| 21 | NASDAQ: VERA VERA THERAPEUTICS INC | $25.58 −2.37% | 0.0% | 241K | $10.4M |
| 22 | NASDAQ: SANA SANA BIOTECHNOLOGY INC | $1.85 −1.60% | 0.0% | 2.8M | $9.8M |
| 23 | NASDAQ: GLUE MONTE ROSA THERAPEUTICS INC | $9.07 0.00% | 0.0% | 372K | $9.0M |
| 24 | NASDAQ: LYEL LYELL IMMUNOPHARMA INC | $13.89 +1.61% | 0.0% | 293K | $4.1M |
| 25 | NYSE: FIG FIGMA INC | $17.33 −4.68% | 0.0% | 216K | $3.9M |
Showing 1–25 of 28 positions on this page reported in this 13F.
- Technology1.8%
- Industrials1.2%
- Healthcare0.9%
- Financial Services0.8%
- NewSPCXSPACE EXPLORATION TECHN CORP—$94.2B
- NewPBLSPARABILIS MEDICINES INC—$134.6M
- NewFRVOFERVO ENERGY CO—$51.5M
- ReducedRVMDREVOLUTION MEDICINES INC−10.5%$551.8M
- ReducedLIFEETHOS TECHNOLOGIES INC−3.9%$65.7M
- ReducedRLAYRELAY THERAPEUTICS INC−9.9%$26.4M
- ReducedGLUEMONTE ROSA THERAPEUTICS INC−45.6%$9.0M
- SoldTNYATENAYA THERAPEUTICS INC−100%—
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | GOOG Alphabet Inc | 13G | 7.5% · 2 classes | 436.0M | Filed 29 APR 2026 |
Showing all 1 disclosed stakes.
Reading Alphabet Inc.’s 13F portfolio
Alphabet Inc.’s $99.1B 13F book is spread across 28 reported positions and is highly concentrated — its ten largest positions alone are 100% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are SPCX, PL, ASTS, CME and ARM, led by SPACE EXPLORATION TECHN CORP (SPCX) at 95% of the portfolio. The heaviest sector exposure is Technology (2%), then Industrials (1%).
What Alphabet Inc. changed last quarter
Between 2026-03-31 and Q2 2026, Alphabet Inc. was a net seller: it opened 3 new positions and added to 0 more, while trimming 4 and closing 1 outright. Against a 28-name book, that is moderate turnover, pointing to steady rotation within the portfolio. Its largest new or increased position was SPACE EXPLORATION TECHN CORP (SPCX), and its biggest reduction was REVOLUTION MEDICINES INC (RVMD).
What a 13F does and doesn’t reveal
A 13F captures only Alphabet Inc.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Alphabet Inc. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Alphabet Inc.'s profile on this page is built directly from those filings.
How current is the 13F data on Alphabet Inc.'s page?
It reflects Alphabet Inc.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Alphabet Inc. files its next quarterly report, this page refreshes automatically.
Can I see Alphabet Inc.'s complete list of holdings?
This page highlights Alphabet Inc.'s largest positions rather than all 28 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Alphabet Inc.'s filings.
Does a 13F show everything Alphabet Inc. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Alphabet Inc.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Alphabet Inc. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

